

Mylin Biotech India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.34 M
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.58 Cr
- Satisfied Charges ₹ 3.50 M
- Revenue Growth 26.95%
- Profit Growth -263.17%
- Ebitda 8.92%
- Net Worth 154.46%
- Total Assets 284.48%
About Mylin Biotech India
Mylin Biotech India Private Limited (MBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 2012 and has a history of 12 years and three months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.34 M.
The company currently has active open charges totaling ₹3.58 Cr. The company has closed loans amounting to ₹3.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kavitha Prabakaran, Ramasamy Pillai, and Pandurangan Prabhakran serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100KA2012PTC067115
- Company No.
067115
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Mylin Biotech India Private Limited offer?
Mylin Biotech India Private Limited offers a wide range of products and services, including Health Conditions, Kidney Care.
Who are the key members and board of directors at Mylin Biotech India?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kavitha Prabakaran ![]() | Director | 10-Dec-2012 | Current |
Ramasamy Pillai ![]() | Director | 10-Dec-2012 | Current |
Pandurangan Prabhakran ![]() | Director | 09-May-2022 | Current |
Financial Performance of Mylin Biotech India.
Mylin Biotech India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.95% increase. The company also saw a substantial fall in profitability, with a 263.17% decrease in profit. The company's net worth Soared by an impressive increase of 154.46%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Mylin Biotech India?
In 2023, Mylin Biotech India had a public holding of 70.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹35.80 M
₹3.50 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 3.26 Cr
- Hdfc Bank Limited : 0.32 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
19 Apr 2022 | State Bank Of India | ₹3.26 Cr | Open |
09 Dec 2020 | Hdfc Bank Limited | ₹3.20 M | Open |
20 May 2021 | Hdfc Bank Limited | ₹3.50 M | Satisfied |
How Many Employees Work at Mylin Biotech India?
Mylin Biotech India has a workforce of 15 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Mylin Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mylin Biotech India's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Mylin Biotech India
Recent activity within the organization
- Annual General Meeting
Mylin Biotech India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Mylin Biotech India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
- Charges
A charge with State Bank Of India of Rs. 32.60 M registered on 19 Apr 2022 with Charge ID 100569454 was modified on 09 Nov 2023.
- Charges
A charge registered on 20 May 2021 via Charge ID 100447909 with Hdfc Bank Limited was fully satisfied on 11 May 2022.
- Director Appointment
Pandurangan Prabhakran was appointed as a Director was appointed as a Director on 09 May 2022 & has been associated with this company since 2 years 10 months .
- Charges
A charge with State Bank Of India amounted to Rs. 32.60 M with Charge ID 100569454 was registered on 19 Apr 2022.
Frequently asked questions
What is the Incorporation or founding date of Mylin Biotech India Private Limited?
Mylin Biotech India Private Limited was incorporated on 10 Dec 2012.
What is authorized share capital and paid-up capital of Mylin Biotech India Private Limited?
The authorized share capital of Mylin Biotech India Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.34 M.
Who are the current board members & directors of Mylin Biotech India Private Limited?
Currently 3 directors are associated with Mylin Biotech India Private Limited.
- Kavitha Prabakaran
- Ramasamy Ramajayam Pillai
- Pandurangan Prabhakran
What is the registered address of Mylin Biotech India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Mylin Biotech India Private Limited is 254/1-9 11Th Main Road 3Rd Phase Peenya Bangalore, - India, Bangalore North, Karnataka, 560058.
What is the corporate identification number (CIN) and company number of Mylin Biotech India Private Limited?
The corporate identification number (CIN) of Mylin Biotech India Private Limited is U73100KA2012PTC067115 and the company number is 067115 as per Ministry of Corporate Affairs (MCA).
What is the official website of Mylin Biotech India Private Limited?
The Official website of Mylin Biotech India Private Limited is https://www.mylinbiotech.com
What has been the recent revenue trend for Mylin Biotech India Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Mylin Biotech India Private Limited has risen by 26.95%.
How many employees does Mylin Biotech India Private Limited currently have?
As Per 2023 financial reports, 15 employees are currently employed by Mylin Biotech India Private Limited.
What change has been observed in the net worth of Mylin Biotech India Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Mylin Biotech India Private Limited has experienced an upsurge of 154.46%.
What are the total open charges for Mylin Biotech India Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Mylin Biotech India Private Limited amount to ₹ 3.58 Cr.
When was the last Balance Sheet of Mylin Biotech India Private Limited filed with the ROC?
The most recent Balance Sheet for Mylin Biotech India Private Limited was filed with the ROC on 31 Mar 2024.